
SCI — Investor Relations & Filings
SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告本公司115年股東常會重要決議事項。 | 2026-05-22 | Chinese | |
| 公告本公司115年第一季財務合併報告董事會預計召開 日期為115年5月7日。 | 2026-04-29 | Chinese | |
| 113年8月變更登記 | 2026-04-21 | Chinese | |
| 公司基本資料 | 2026-04-21 | Chinese | |
| 115年年報及股東會資料 — 2026_4119_20260522F13.pdf | 2026-04-17 | Chinese | |
| 115年年報及股東會資料 — 2026_4119_20260522F17.pdf | 2026-04-17 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46764743 | 公告本公司115年股東常會重要決議事項。 | 2026-05-22 | Chinese | ||
| 38492599 | 公告本公司115年第一季財務合併報告董事會預計召開 日期為115年5月7日。 | 2026-04-29 | Chinese | ||
| 34696999 | 113年8月變更登記 | 2026-04-21 | Chinese | ||
| 34697023 | 公司基本資料 | 2026-04-21 | Chinese | ||
| 34655412 | 115年年報及股東會資料 — 2026_4119_20260522F13.pdf | 2026-04-17 | Chinese | ||
| 34655409 | 115年年報及股東會資料 — 2026_4119_20260522F17.pdf | 2026-04-17 | Chinese | ||
| 34655407 | 115年年報及股東會資料 — 2026_4119_20260522F02.pdf | 2026-04-17 | Chinese | ||
| 34655403 | 115年年報及股東會資料 — 2026_4119_20260522F01.pdf | 2026-04-17 | Chinese | ||
| 34644347 | 114年第4季財務報告書 — 202504_4119_AIC.pdf | 2026-04-16 | English | ||
| 34644337 | 114年第4季財務報告書 — 202504_4119_AIA.pdf | 2026-04-16 | English | ||
| 34644329 | 114年第4季財務報告書 — 202503_4119_AI1.pdf | 2026-04-16 | Chinese | ||
| 34644293 | 114年第4季財務報告書 — 202502_4119_AIA.pdf | 2026-04-16 | English | ||
| 33874334 | 115年03月內部人持股異動(事後) | 2026-04-09 | Chinese | ||
| 33874333 | 115年03月董事會成員及持股 | 2026-04-09 | Chinese | ||
| 33799524 | 115年3月背書保證與資金貸與 | 2026-04-08 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Chongqing Zhifei Biological Products Co.,Ltd.
Develops and distributes vaccines and biological products v…
|
300122 | CN | Manufacturing |
|
CHOONG ANG VACCINE LABORATORY
Develops and manufactures vaccines, pharmaceuticals, and fe…
|
072020 | KR | Manufacturing |
|
CHOSA Oncology AB
Develops diagnostics and therapeutics for platinum-based ch…
|
CHOSA | SE | Manufacturing |
|
CHUGAI PHARMACEUTICAL CO., LTD.
A research-driven pharmaceutical company developing innovat…
|
4519 | JP | Manufacturing |
|
CHUKYOIYAKUHIN CO.,LTD.
Offers health products and pharmaceuticals via a direct-to-…
|
4558 | JP | Manufacturing |
|
Cian Healthcare Limited
WHO-GMP certified manufacturer of diverse healthcare produc…
|
542678 | IN | Manufacturing |
|
Cidara Therapeutics, Inc.
Develops targeted immunotherapies and anti-infectives for s…
|
CDTX | US | Manufacturing |
|
CILO CYBIN HOLDINGS LIMITED
Vertically integrated medical cannabis company with GACP cu…
|
CCCE | ZA | Manufacturing |
|
Cinclus Pharma Holding AB
Clinical-stage pharma company developing a PCAB for gastric…
|
CINPHA | SE | Manufacturing |
|
Cingulate Inc.
A clinical-stage biopharma firm developing treatments for A…
|
CING | US | Manufacturing |
SCI via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52383/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52383 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52383 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52383 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52383}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SCI (id: 52383)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.